Daiichi Sankyo Co., Ltd. engages in the research, development, manufacture, and sale of pharmaceuticals. The company is headquartered in Chuo-Ku, Tokyo-To and currently employs 19,765 full-time employees. The company went IPO on 2005-09-28. The firm is involved in the research, development, manufacture and sale of pharmaceuticals, as well as the provision of intermediates and basic materials for pharmaceutical producing in Japan, the United States, Europe and other markets. The firm is also engaged in the research, development, manufacture and sale of over-the-counter drugs and vaccines, the provision of administrative services such as human resources and accounting services, real estate leasing and insurance agency business.
Daiichi Sankyo Company, Limited có cổ tức hàng năm là 60.4188 mỗi cổ phiếu, với tỷ suất là 0.00%. Cổ tức được trả nửa năm và ngày ex-dividend cuối cùng là Sep 29, 2025.